DiscoverThe Cannabis Conversation | Medical Cannabis | CBD | HempEPISODE #158 Psychedelics: The Investment Case with Jaspreet Grewal, Mitchell Osak, & Steve Hajioff
EPISODE #158 Psychedelics: The Investment Case with Jaspreet Grewal, Mitchell Osak, & Steve Hajioff

EPISODE #158 Psychedelics: The Investment Case with Jaspreet Grewal, Mitchell Osak, & Steve Hajioff

Update: 2022-03-23
Share

Description

This week, we’re joined by Jaspreet Grewal, Mitchell Osak, & Steve Hajioff - three subject matter specialists within the psychedelics space.

In this special panel episode, we explore the emergence (and re-emergence) of therapeutic psychedelics, including examining the substances which have gained early traction, the investment case for them, and the challenges and opportunities of this new sector.

 

📚 VIEW SHOW NOTES AND EXTRAS:
https://www.canverse.global/shownotes/e158


Quotables

[Psilocybin] can't be viewed as a miracle drug for everybody. I think that's really what it comes down to. We have to be very pragmatic that it's still an investigational compound. - Jaspreet



Resources

Connect with Steve on Linkedin: https://www.linkedin.com/in/stevehajioff/?originalSubdomain=uk

Connect with Jaspreet on Linkedin: https://www.linkedin.com/in/jkgrewal/

Connect with Mitchell on Linkedin:  https://www.linkedin.com/in/mitchellosak/



Comments 
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

EPISODE #158 Psychedelics: The Investment Case with Jaspreet Grewal, Mitchell Osak, & Steve Hajioff

EPISODE #158 Psychedelics: The Investment Case with Jaspreet Grewal, Mitchell Osak, & Steve Hajioff

Anuj Desai with Jaspreet Grewal, Mitchell Osak, & Steve Hajioff